Lung resection in hematologic patients with pulmonary invasive fungal disease

Chest

Volumn 142, Issue 4, 2012, Pages 988-995

  Nebiker, Christian A ^a   Lardinois, Didier ^a   Junker, Lilian ^a   Gambazzi, Franco ^a   Matt, Peter ^a   Habicht, James M ^a   Halter, Joerg ^a   Heim, Dominik ^a   Stern, Martin ^a   Buser, Andreas S ^a   Passweg, Jakob ^a   Stolz, Daiana ^a   Flückiger, Ursula M ^a   Weisser, Maja ^a   Battegay, Manuel ^a   Bubendorf, Lukas ^a   Gratwohl, Alois ^a   Tamm, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTINEOPLASTIC AGENT; FLUCONAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER PATIENT; CHILD; CHYLOTHORAX; COHORT ANALYSIS; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HEMATOLOGIC MALIGNANCY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LUNG LOBECTOMY; LUNG MYCOSIS; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NEUTROPENIA; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; SCHOOL CHILD; SEROMA; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTE COUNT; TREATMENT OUTCOME; WOUND DEHISCENCE;

EID: 84867114795     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-1964     Document Type: Article

References (32)

1. Denning DW. Invasive aspergillosis. Clin Infect Dis. 1998;26(4):781-803.
2. Ascioglu S, Rex JH, de Pauw B, et al Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer; Mycoses Study Group of the National Institute of Allergy and Infectious Diseases. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34(1):7-14. (Pubitemid 33152659)
3. De Pauw B, Walsh TJ, Donnelly JP, et al European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46(12):1813-1821.
4. Brook O, Guralnik L, Hardak E, et al. Radiological findings of early invasive pulmonary aspergillosis in immune-compromised patients. Hematol Oncol. 2009;27(2):102-106.
5. Jantunen E, Piilonen A, Volin L, et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant. 2000;25(8):867-871. (Pubitemid 30209680)
6. Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients. Drugs. 2007;67(11):1567-1601. (Pubitemid 47267298)
7. Matt P, Bernet F, Habicht J, et al. Predicting outcome after lung resection for invasive pulmonary aspergillosis in patients with neutropenia. Chest. 2004;126(6):1783-1788. (Pubitemid 39643980)
8. Herbrecht R, Denning DW, Patterson TF, et al; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspe rgillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408-415.
9. Upton A, Kirby KA, Carpenter P, Boeckh M, Marr KA. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality. Clin Infect Dis. 2007;44(4):531-540. (Pubitemid 46233255)
10. Denning DW, Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis. 2002;34(5):563-571. (Pubitemid 34165316)
11. Danner BC, Didilis V, Dörge H, Mikroulis D, Bougioukas G, Schöndube FA. Surgical treatment of pulmonary aspergillosis/mycosis in immunocompromised patients. Interact Cardiovasc Thorac Surg. 2008;7(5):771-776.
12. Habicht JM, Matt P, Passweg JR, et al. Invasive pulmonary fungal infection in hematologic patients: is resection effective? Hematol J. 2001;2(4):250-256. (Pubitemid 32771599)
13. Pidhorecky I, Urschel J, Anderson T. Resection of invasive pulmonary aspergillosis in immunocompromised patients. Ann Surg Oncol. 2000;7(4):312-317. (Pubitemid 30318321)
14. Reichenberger F, Habicht J, Kaim A, et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med. 1998;158(3):885-890. (Pubitemid 28449456)
15. Caillot D, Mannone L, Cuisenier B, Couaillier JF. Role of early diagnosis and aggressive surgery in the management of invasive pulmonary aspergillosis in neutropenic patients. Clin Microbiol Infect. 2001;7(suppl 2):54-61.
16. Herbrecht R, Natarajan-Amé S, Letscher-Bru V, Canuet M. Invasive pulmonary aspergillosis. Semin Respir Crit Care Med. 2004;25(2):191-202. (Pubitemid 38552370)
17. Weisser M, Rausch C, Droll A, et al. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies. Clin Infect Dis. 2005;41(8):1143-1149. (Pubitemid 41429477)
18. Dutkiewicz R, Hage CA. Aspergillus infections in the critically ill. Proc Am Thorac Soc. 2010;7(3):204-209.
19. Orasch C, Weisser M, Mertz D, et al. Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2010;45(3):521-526.
20. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol. 1997;15(1):139-147. (Pubitemid 27020567)
21. Robinson LA, Reed EC, Galbraith TA, Alonso A, Moulton AL, Fleming WH. Pulmonary resection for invasive Aspergillus infections in immunocompromised patients. J Thorac Cardiovasc Surg. 1995;109(6):1182-1196.
22. Baron O, Guillaumé B, Moreau P, et al. Aggressive surgical management in localized pulmonary mycotic and nonmy cotic infections for neutropenic patients with acute leukemia: report of eighteen cases. J Thorac Cardiovasc Surg. 1998;115(1):63-68.
23. Salerno CT, Ouyang DW, Pederson TS, et al. Surgical therapy for pulmonary aspergillosis in immunocompromised patients. Ann Thorac Surg. 1998;65(5):1415-1419. (Pubitemid 28241706)
24. Habicht JM, Reichenberger F, Gratwohl A, Zerkowski HR, Tamm M. Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients. Ann Thorac Surg. 1999;68(2):321-325. (Pubitemid 29521069)
25. Yeghen T, Kibbler CC, Prentice HG, et al. Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution. Clin Infect Dis. 2000;31(4):859-868. (Pubitemid 32299339)
26. Matt P, Bernet F, Habicht J, et al. Short- and long-term outcome after lung resection for invasive pulmonary aspergillosis. Thorac Cardiovasc Surg. 2003;51(4):221-225. (Pubitemid 37229337)
27. Azzola A, Passweg JR, Habicht JM, et al. Use of lung resection and voriconazole for successful treatment of invasive pulmonary Aspergillus ustus infection. J Clin Microbiol. 2004;42(10):4805-4808. (Pubitemid 39362408)
28. Dunst KM, Mueller LC. Surgical management of bilateral multiple invasive pulmonary aspergillosis. J Thorac Cardiovasc Surg. 2004;128(4):621-622. (Pubitemid 39278400)
29. Massard G. Role of surgery in the treatment of pulmonary aspergillosis [in French]. Rev Mal Respir. 2005;22(3):466-472. (Pubitemid 41020468)
30. Nosari A, Ravini M, Cairoli R, et al. Surgical resection of persistent pulmonary fungus nodules and secondary prophylaxis are effective in preventing fungal relapse in patients receiving chemotherapy or bone marrow transplantation for leukemia. Bone Marrow Transplant. 2007;39(10):631-635. (Pubitemid 46722843)
31. Cesaro S, Cecchetto G, De Corti F, et al. Results of a multicenter retrospective study of a combined medical and surgical approach to pulmonary aspergillosis in pediatric neutro penic patients. Pediatr Blood Cancer. 2007;49(7):909-913. (Pubitemid 350022444)
32. Gow KW, Hayes-Jordan AA, Billups CA, et al. Benefit of surgical resection of invasive pulmonary aspergillosis in pediatric patients undergoing treatment for malignancies and immunodeficiency syndromes. J Pediatr Surg. 2003;38(9):1354-1360. (Pubitemid 37159087)